Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Pyrexia, SARS-CoV-2 test
Clinical narrative: bothered throat  after receiving second booster dose of Moderna Covid19 vaccine; Cannot swallow  after receiving second booster dose of Moderna Covid19 vaccine; left side gland under the chin swollen  after receiving second booster dose of Moderna Covid19 vaccine; fever over 100 degrees  after receiving second booster dose of Moderna Covid19 vaccine; First booster dose - 22Dec2021 and Second booster dose-04Apr2022; Feeling sick after receiving second booster dose of Moderna Covid19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Feeling sick after receiving second booster dose of Moderna Covid19 vaccine), OROPHARYNGEAL DISCOMFORT (bothered throat  after receiving second booster dose of Moderna Covid19 vaccine), DYSPHAGIA (Cannot swallow  after receiving second booster dose of Moderna Covid19 vaccine), LYMPHADENOPATHY (left side gland under the chin swollen  after receiving second booster dose of Moderna Covid19 vaccine) and PYREXIA (fever over 100 degrees  after receiving second booster dose of Moderna Covid19 vaccine) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L21B, 018F21A, 022M2704 and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tumor (she had a tumor on the airway, and she had surgery because of it.), COVID-19 (The patient states she had very strong symptoms and could not breath.) on 27-Mar-2020 and Surgery (Tumor surgery). Concurrent medical conditions included Allergy (allergic to hot temperature), Allergy to antibiotic (Allergic to all antibiotics except for Doxycycline Hyclate), Rheumatoid arthritis (caller was 19 she was diagnosed), Hypothyroidism (caller was 19 she was diagnosed) and Asthma (caller was 19 she was diagnosed). Concomitant products included LEVOTHYROXINE and HYDROXYCHLOROQUINE for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2022, the patient experienced ILLNESS (Feeling sick after receiving second booster dose of Moderna Covid19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First booster dose - 22Dec2021 and Second booster dose-04Apr2022). On 05-Apr-2022, the patient experienced OROPHARYNGEAL DISCOMFORT (bothered throat  after receiving second booster dose of Moderna Covid19 vaccine), DYSPHAGIA (Cannot swallow  after receiving second booster dose of Moderna Covid19 vaccine), LYMPHADENOPATHY (left side gland under the chin swollen  after receiving second booster dose of Moderna Covid19 vaccine) and PYREXIA (fever over 100 degrees  after receiving second booster dose of Moderna Covid19 vaccine). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, ILLNESS (Feeling sick after receiving second booster dose of Moderna Covid19 vaccine), OROPHARYNGEAL DISCOMFORT (bothered throat  after receiving second booster dose of Moderna Covid19 vaccine), DYSPHAGIA (Cannot swallow  after receiving second booster dose of Moderna Covid19 vaccine), LYMPHADENOPATHY (left side gland under the chin swollen  after receiving second booster dose of Moderna Covid19 vaccine), PYREXIA (fever over 100 degrees  after receiving second booster dose of Moderna Covid19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First booster dose - 22Dec2021 and Second booster dose-04Apr2022) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2020, SARS-CoV-2 test: positive (Positive) Positive. On 05-Apr-2022, Body temperature: over 100 degrees (High) over 100 degrees.         Patient had Covid on 27March2020, but doctor refused to test people who did not come in ships. The patient stated she had very strong symptoms and could not breath.   This case was linked to MOD-2022-534490, MOD-2022-534390 (Patient Link).